In this review:
Concurrent treatment of AA/PNH syndrome
Nivolumab for relapsed/refractory HL
Ibrutinib in patients with CLL/SLL ±
11q deletion
Rituximab vs obinutuzumab for NHL
The real world use of bosutinib in chronic myeloid leukaemia
Ruxolitinib in patients with myelofibrosis
Elderly AML: treatment patterns and outcomes
Minimising unnecessary blood testing for NHL
Granulocyte transfusions: a UK survey
Pegfilgrastim vs filgrastim for stem cell mobilisation in multiple myeloma
Please login below to download this issue (PDF)